NCT04629222

Brief Summary

Tracheobronchitis signs may be observed on ventilation lung scintigraphy during coronavirus disease (COVID-19) infection. This case report study aimed to analyze the rates and associated factors of such tracheobronchitis in COVID-19 patients referred to ventilation/perfusion lung scintigraphy with shortness of breath, suspected of pulmonary embolism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2020

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 16, 2020

Completed
Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

4 months

First QC Date

November 13, 2020

Last Update Submit

June 18, 2024

Conditions

Infectious Disease of Lung

Keywords

Coronavirus Disease (COVID-19)Lung ventilationPerfusion scintigraphyTracheobronchitisShortness of breathCadmium-Zinc-Telluride (CZT)-SPECTComputer Tomography (CT)

Outcome Measures

Primary Outcomes (1)

  • Tracheobronchitis signs may be observed on ventilation lung scintigraphy during COVID-19 infection.

    analyze the rates and associated factors of such tracheobronchitis in COVID-19 patients referred to ventilation/perfusion lung scintigraphy with shortness of breath, suspected of pulmonary embolism.

    1 month

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients experiencing shortness of breath during the course of a COVID-19

You may qualify if:

  • patient with Tracheobronchitis signs
  • patient with lung scintigraphy exam

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU of Nancy

Vandœuvre-lès-Nancy, 54511, France

Location

MeSH Terms

Conditions

COVID-19Dyspnea

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 13, 2020

First Posted

November 16, 2020

Study Start

March 11, 2020

Primary Completion

July 20, 2020

Study Completion

July 23, 2020

Last Updated

June 21, 2024

Record last verified: 2024-06

Locations

FR(1)